Predictors of efficacy in patients (pts) with hormone receptor–positive/ human epidermal growth factor receptor 2–negative advanced breast cancer (HR+/HER2− ABC): Subgroup analyses of PALOMA-3

H. Rugo, M. Cristofanilli, S. Loibl, N. Harbeck, A. Demichele, H. Iwata, Y. H. Park, A. Brufsky, K. Puyana Theall, X. Huang, L. McRoy, E. Bananis, N. C. Turner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S7-S8
JournalEuropean Journal of Cancer
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this